Bio-Reference Labs Reinitiated at Buy and 4 Reinitiated Ratings to Know Now

Stock upgrades and downgrades are a controversial part of Wall Street. Despite regulations, many banks and firms still have a positive bias toward current clients and companies desired as future clients. In addition, Wall Street analysts are straight-up biased to the buy side. The percentage of sell recommendations is normally below 15 percent!

Regardless, upgrades and downgrades move stocks in the short-term. They fall into our CHEAT SHEET framework category ‘C = Catalyst for a Stock?s Movement’. Here are catalysts you must know today:

Valeant Pharmaceuticals (NYSE:VRX): Ladenburg Thalmann reiterated its rating of Buy for this company and changed its price target from $75 to $84.

The stock market is roaring back in 2013. Click here now to discover winning stocks!